NEUTROPEG pegfilgrastim 6 mg/0.6 mL solution for injection pre-filled syringe

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

Pegfilgrastim, Quantity: 6 mg

Verfügbar ab:

Accord Healthcare Pty Ltd

Darreichungsform:

Injection, solution

Zusammensetzung:

Excipient Ingredients: glacial acetic acid; polysorbate 20; sodium hydroxide; sorbitol; water for injections

Verabreichungsweg:

Subcutaneous

Einheiten im Paket:

1 prefilled syringe

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

For the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Produktbesonderheiten:

Visual Identification: clear and colourless liquid; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Registered

Berechtigungsdatum:

2019-08-19